Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab. 2013;98(10):3920–5.
Article PubMed Central CAS PubMed Google Scholar
Benson CT. Prolactin Medscape: Medscape; 2023. Available from: https://emedicine.medscape.com/article/124526-overview?form=fpf. Accessed 27 Dec 2023.
Amin M, Gragnoli C. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome. J Ovarian Res. 2023;16(1):222.
Article PubMed Central CAS PubMed Google Scholar
Le JA, Wilson HM, Shehu A, Mao J, Devi YS, Halperin J, et al. Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function. Biol Reprod. 2012;86(3):86.
Baumgard LH, Hausman GJ, Sanz Fernandez MV. Insulin: pancreatic secretion and adipocyte regulation. Domest Anim Endocrinol. 2016;54:76–84.
Article CAS PubMed Google Scholar
Macotela Y, Triebel J, Clapp C. Time for a New Perspective on Prolactin in Metabolism. Trends Endocrinol Metab. 2020;31(4):276–86.
Article CAS PubMed Google Scholar
Zhang Z, Piro AL, Allalou A, Alexeeff SE, Dai FF, Gunderson EP, et al. Prolactin and Maternal Metabolism in Women With a Recent GDM Pregnancy and Links to Future T2D: The SWIFT Study. J Clin Endocrinol Metab. 2022;107(9):2652–65.
Article PubMed Central PubMed Google Scholar
Fleenor DE, Freemark M. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology. 2001;142(7):2805–10.
Article CAS PubMed Google Scholar
Mráziková L, Neprašová B, Mengr A, Popelová A, Strnadová V, Holá L, et al. Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models. Front Pharmacol. 2021;12:779962.
Article PubMed Central PubMed Google Scholar
Kooijman R, Gerlo S, Coppens A, Hooghe-Peters EL. Growth hormone and prolactin expression in the immune system. Ann N Y Acad Sci. 2000;917:534–40.
Article CAS PubMed Google Scholar
Gregory LC, Cionna C, Cerbone M, Dattani MT. Identification of genetic variants and phenotypic characterization of a large cohort of patients with congenital hypopituitarism and related disorders. Genet Med. 2023;25(9):100881.
Article CAS PubMed Google Scholar
Aitkenhead H, Heales SJ. Establishment of paediatric age-related reference intervals for serum prolactin to aid in the diagnosis of neurometabolic conditions affecting dopamine metabolism. Ann Clin Biochem. 2013;50(Pt 2):156–8.
Article CAS PubMed Google Scholar
Davis SW, Castinetti F, Carvalho LR, Ellsworth BS, Potok MA, Lyons RH, et al. Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes. Mol Cell Endocrinol. 2010;323(1):4–19.
Article CAS PubMed Google Scholar
Procter AM, Phillips JA 3rd, Cooper DN. The molecular genetics of growth hormone deficiency. Hum Genet. 1998;103(3):255–72.
Article CAS PubMed Google Scholar
Mukherjee A, Ryder WD, Jöstel A, Shalet SM. Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults. J Clin Endocrinol Metab. 2006;91(7):2520–5.
Article CAS PubMed Google Scholar
Veldhuis JD. Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol. 2013;9(4):205–15.
Article PubMed Central CAS PubMed Google Scholar
Alatzoglou KS, Dattani MT. Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev. 2009;85(11):705–12.
Article CAS PubMed Google Scholar
Bosch IAL, Katugampola H, Dattani MT. Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome. Front Pediatr. 2020;8:600962.
Blum WF, Klammt J, Amselem S, Pfäffle HM, Legendre M, Sobrier ML, et al. Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes. EBioMedicine. 2018;36:390–400.
Article PubMed Central PubMed Google Scholar
Kelberman D, Dattani MT. Genetics of septo-optic dysplasia. Pituitary. 2007;10(4):393–407.
Article CAS PubMed Google Scholar
Turton JP, Reynaud R, Mehta A, Torpiano J, Saveanu A, Woods KS, et al. Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab. 2005;90(8):4762–70.
Article CAS PubMed Google Scholar
Toledano Y, Lubetsky A, Shimon I. Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest. 2007;30(4):268–73.
Article CAS PubMed Google Scholar
Uzun I, Karaca Z, Hacioğlu A, Unluhizarci K, Kelestimur F. The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions. Pituitary. 2024;27(3):277.
Article PubMed Central PubMed Google Scholar
Krysiak R, Kowalcze K, Okopień B. Sexual function and depressive symptoms in young women with hypoprolactinaemia. Clin Endocrinol (Oxf). 2020;93(4):482–8.
Article CAS PubMed Google Scholar
Oseko F, Nakano A, Morikawa K, Endo J, Taniguchi A, Usui T. Effects of chronic bromocriptine-induced hypoprolactinemia on plasma testosterone responses to human chorionic gonadotropin stimulation in normal men. Fertil Steril. 1991;55(2):355–7.
Article CAS PubMed Google Scholar
Rastrelli G, Corona G, Maggi M. The role of prolactin in andrology: what is new? Rev Endocr Metab Disord. 2015;16(3):233–48.
Article CAS PubMed Google Scholar
Gács G, Sólyom J, Jakabfi P, Fehér T. Does hypoprolactinaemia affect adrenal androgen levels in children with hypopituitarism? Horm Metab Res. 1989;21(9):529–30.
Macotela Y, Ruiz-Herrera X, Vázquez-Carrillo DI, Ramírez-Hernandez G. Martínez de la Escalera G, Clapp C The beneficial metabolic actions of prolactin. Front Endocrinol (Lausanne). 2022;13:1001703.
Ruiz-Herrera X, de Los Ríos EA, Díaz JM, Lerma-Alvarado RM, Martínez de la Escalera L, López-Barrera F, et al. Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males. Endocrinology 2017;158(1):56–68.
Holstad M, Sandler S. Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice. J Endocrinol. 1999;163(2):229–34.
Park S, Kim DS, Daily JW, Kim SH. Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats. Diabetes Metab Res Rev. 2011;27(6):564–74.
Yu J, Xiao F, Zhang Q, Liu B, Guo Y, Lv Z, et al. PRLR regulates hepatic insulin sensitivity in mice via STAT5. Diabetes. 2013;62(9):3103–13.
Article PubMed Central CAS Google Scholar
Ponce AJ, Galván-Salas T, Lerma-Alvarado RM, Ruiz-Herrera X, Hernández-Cortés T, Valencia-Jiménez R, et al. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine. 2020;67(2):331–43.
Comments (0)